Explore

Site selection

Plan the next phase footprint from peer trials in your indication: countries, active facilities, and registry-reported enrollment signals.

Methodology (v1)

  • Peer set: same primary condition as the anchor trial, filtered to benchmark phases (by default, Phase 3 when the anchor is Phase 2), plus any NCT IDs you add manually.
  • Data: facility and country fields from ClinicalTrials.gov location modules; enrollment from study design when reported.
  • Country score: weighted mix of peer trial count, distinct facilities, recruiting peers, and average enrollment per listed site across peers.
  • Compare A vs B: two scenario configs on the same anchor; rank delta shows how country priority shifts when weights or peer sets change.
  • Limitations: registry site lists are incomplete and lag protocol amendments; no patient counts or investigator master data. For competitor-aware refresh, pair with trial alerts and portfolio watches.

Full design and vendor landscape: docs/site-selection/design.md in the repo.